Price to Book Value Chart

View Price to Book Value for CRNX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to Book Value Chart
Start Trial

Historical Price to Book Value Data

View and export this data back to 2018. Start Trial.
Date Value
August 21, 2026 7.518
August 20, 2026 7.518
August 19, 2026 7.518
August 18, 2026 7.520
August 17, 2026 7.523
August 14, 2026 7.519
August 13, 2026 7.496
August 12, 2026 7.497
August 11, 2026 7.488
August 10, 2026 7.470
August 07, 2026 7.464
August 06, 2026 7.449
August 05, 2026 7.456
August 04, 2026 7.444
August 03, 2026 7.435
July 31, 2026 7.414
July 30, 2026 7.424
July 29, 2026 7.446
July 28, 2026 7.444
July 27, 2026 7.443
July 24, 2026 7.432
July 23, 2026 7.425
July 22, 2026 7.432
July 21, 2026 7.448
July 20, 2026 7.445
Date Value
July 17, 2026 7.444
July 16, 2026 7.448
July 15, 2026 7.448
July 14, 2026 7.431
July 13, 2026 7.427
July 10, 2026 7.419
July 09, 2026 7.423
July 08, 2026 7.411
July 07, 2026 7.415
July 06, 2026 3.731
July 02, 2026 3.749
July 01, 2026 3.434
June 30, 2026 3.322
June 29, 2026 3.038
June 26, 2026 3.018
June 25, 2026 2.877
June 24, 2026 2.975
June 23, 2026 2.953
June 22, 2026 2.910
June 18, 2026 2.950
June 17, 2026 2.940
June 16, 2026 2.878
June 15, 2026 2.888
June 12, 2026 2.835
June 11, 2026 2.757

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Vertex Pharmaceuticals, Inc. 6.854
Johnson & Johnson 7.739
Eli Lilly & Co. 34.67
Pfizer Inc. 1.872
Bristol Myers Squibb Co. 6.161

Price to Book Value Related Metrics

PS Ratio 200.62
PEG Ratio -0.7410
Price 84.79
Earnings Yield -5.95%
Market Cap 8.971B
PEGY Ratio -0.7410